For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare.
RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
Episode Title: “Hiring Heat Check: What’s Hot in Biotech + Pharma Talent in Mid-2025” 🎙️ Hosts: Ian Wendt & Na-Ri Oh 🎧 Guest: Kristiaan Rawlings, Executive Recruiter at EPM Scientific Episode Overview: This week, fan favorite...
🎙 Episode Title: The Future of Biotech Guest: Andrew Craig, Founder of Plain English Finance | Author of Our Future is Biotech 📌 Episode Summary In this bold and wide-ranging conversation, Ian Wendt and Na-Ri Oh sit down with...
🎙 Episode Title: Rooted in Results: The Future of Functional Medicine with Dr. Erica Armstrong 🧬 Episode Summary In this episode, Dr. Na-Ri Oh and Ian Wendt sit down with Dr. Erica Armstrong, board-certified family medicine p...
🎙️ RealPharma Podcast Episode Title: Cracking the Code on Patient Engagement: Conversational AI with Dan Fox 🗓️ Release Date: May 5, 2025 🎧 Hosts: Dr. Na-Ri Oh & Ian Wendt 🎤 Guest: Dan Fox, Managing Director of Healthcare at ...
In this powerful and deeply human episode of RealPharma , we’re joined by Grace Magedman, PharmD—former Chief Pharmacy Officer at Children’s Hospital of Orange County, functional medicine practitioner, and founder of The Magi...
In this second part of our deep dive into hematology and oncology, we welcome back Dr. Yaming Wang, founder of Alphabet Health LTD and an expert in molecular oncology, pharmaceutical strategy, and medical education. Building ...
As an innovative biopharmaceutical leader with a medical background in Infectious Diseases, Na-Ri Oh, MD brings a unique blend of clinical and business acumen to the table. Na-Ri has held a wide variety of commercial and strategy leadership roles in multiple pharmaceutical companies. Nari has over two decades of experience in clinical patient care and research as well as leading global marketing and strategic planning initiatives, particularly in the areas of HIV, viral hepatitis, and liver disease. Na-Ri is especially passionate about global public health and alternative commercialization models in emerging markets.
Ian Wendt has over three decades of experience in the biotechnology and pharmaceutical sectors. Ian is currently serving as the Chief Commercial Officer at an emerging biotechnology company. Prior to his current role, Ian has held leadership positions at a variety of large pharmaceutical companies leading national teams and driving market development outcomes in HIV treatment and prevention, and hepatitis C. His expertise spans business strategy, revenue and profit growth, and cross-functional leadership, making him a sought-after voice in the industry.